Latest research on allergies: Specific immunotherapy can help

The German Institute for Quality and Efficiency in Health Care has assessed recent evidence on allergies. It found that the once controversial immune therapy against allergy symptoms can definitely help many people with allergies.

When it is green and the flowers have returned, the allergy season has hit its peak. And the number of people affected is still rising. At least 1 in 5 people in get hayfever, and up to half of the population react at least sometimes to airborne allergens like pollen or house dust mites. But we still do not why allergies increased so much in recent decades. The Director of the Institute, Professor Peter Sawicki, said today that none of the theories about the increase in allergies has been proven. For example, childhood immunisation does not seem to be responsible for the growth of allergies.

"There are many unproven claims about allergies,” said Professor Sawicki, "but there is also a growing body of research that has sifted out some facts from the myths. For example, expensive and time-consuming effort like removing all carpets from the house or washing bedlinen very frequently will be a waste for most people: it really is not possible to remove all the allergens from the house, no matter how hard you try. But there are things that can work, like specific immune therapy. And a range of drugs can reduce symptoms."

The Institute has reviewed the latest independent analyses of allergy research to find out which treatments or prevention measures could really work. Allergen immunotherapy can done by injections or sublingual ("under the tongue") drops, tablets or sprays. Both injections and sublingual treatments work. A report* shows that more than a dozen of these immunotherapy extracts are now amongst the 3,000 most prescribed medicines in Germany.

According to Professor Sawicki, "Sublingual therapy in particular is becoming very popular in Europe. Research has shown that it can reduce allergic symptoms in adults and it causes less adverse reactions than injections. We are still not completely certain if it is as effective as injections, or whether it works for children. But many more trials are being done and we expect good answers to these questions soon."

In , the use of anti-histamines has dropped greatly in recent years. The Institute also examined the latest research on some of the biggest-selling anti-histamines. They can all relieve symptoms, but adverse effects are common with all of them. Some might provide relief more quickly than others, and some might have more adverse effects.

The Institute also looked at what might work to prevent allergies developing in children and came to several conclusions. If the parents quit smoking, this can help. Some infant formulas can occasionally cause some allergies. And there are early signs that pregnant women taking probiotics late in pregnancy might be able to help.

"Probiotics in pregnancy is an area of research the Institute will continue to monitor, to see whether trials establish whether or not this can really prevent allergies," according to Professor Sawicki.

Source: Institute for Quality and Efficiency in Health Care

Related stories:

Cell that triggers symptoms in allergy attacks can also limit damage
A blood cell known as a troublemaker for triggering the itch and inflammation in allergy attacks, the mast cell, can also calm down the flare-ups, researchers from Stanford University School of Medicine have found.
Newly identified cells make fat
To understand where fat comes from, you have to start with a skinny mouse. By using such a creature, and observing the growth of fat after injections of different kinds of immature cells, scientists at the Howard Hughes Medical Institute and Rockefeller University have discovered an important fat precursor cell that may in time explain how changes in the numbers of fat cells might increase and lead to obesity. The finding, published online in this week's issue of the journal Cell, could also have implications for understanding how fat cells affect conditions such as diabetes and cardiovascular disease.
Probiotic bacteria can induce monocyte-derived dendritic cells maturation?
Probiotic bacteria are widely used to relieve the symptoms of many disorders such as inflammatory bowel syndrome, diarrhea, and allergies. Probiotic mixtures have also been found to reduce the symptoms of diarrhea. In children a probiotic bacterium L. rhamnosus GG has been shown to prevent the onset of atopy and allergies. However, the mechanisms that cause these beneficial actions are yet to be characterized. One of the factors contributing to the health promoting effects of probiotic bacteria could be their capacity to induce cytokine production that further regulates the development of innate and adaptive immune responses.
Scientists turn human skin cells into insulin-producing cells
(PhysOrg.com) -- Researchers at the University of North Carolina at Chapel Hill School of Medicine have transformed cells from human skin into cells that produce insulin, the hormone used to treat diabetes.
Scientists' findings may lead to new drug-abuse treatments
Increased connections among brain cells caused by excessive drug use may represent the body's defense mechanism to combat addiction and related behaviors, scientists at UT Southwestern Medical Center have found.
Munich researchers discover key allergy gene
Together with colleagues from the Department of Dermatology and Allergy and the Center for Allergy and Environment of the Technische Universität München, scientists at the Helmholtz Zentrum München have pinpointed a major gene for allergic diseases. The gene was localized using cutting edge technologies for examining the whole human genome at the Helmholtz Zentrum München.
Limbs saved by menstrual blood stem cells
Cells obtained from menstrual blood, termed 'endometrial regenerative cells' (ERCs) are capable of restoring blood flow in an animal model of advanced peripheral artery disease. A study published today in BioMed Central's open access Journal of Translational Medicine demonstrates that when circulation-blocked mice were treated with ERC injections, circulation and functionality were restored.
Immune response to human embryonic stem cells in mice suggests human therapy may face challenge
Human embryonic stem cells trigger an immune response in mice, researchers from the Stanford University School of Medicine report. The finding suggests that the effectiveness of human therapies derived from the cells could be limited unless ways are found to dampen the rejection response.

News discussion:

Medicine & Health news